Table 1 Synthesized cyclic oligoribonucleotides
Mass spectrometry
calc. found
608.09
624.08
610.07
610.07
Crude
Purity (%)
(HPLC)
Entry
Oligonucleotide-resin
Cyclic oligonucleotide yield (%)
1
2
3
4
5
6
7
8
9
T-T-R
T-UOMe-R
UOFpmp-T-R
T-UOFpmp-R
c(TT)
50
43
48
14
3
19
33
7
> 90
> 90
> 90
80
—
75
69
57
70
80d
80d
608.29b
624.20b
610.39b
610.39b
c(TUOMe
c(UT)
c(TU)
c(UU)
c(UUUT)
c(CUCT)
c(UUUUUT)
c(UGCUUGCT)
c(UAUAGUOMe
)
UOFpmp-UOFpmp-R
612.09
—
UUU-T-Ra
1222.12
1220.15
1834.17
2523.49
1935.57
1934.26
1222.14c
1222.20c
1834.76c
2521.39c
1933.56c
1932.84c
CUC-T-Ra
UUUUU-T-Ra
UGCUUGC-T-Ra
UAUAG-UOMe-Ra
UAGCA-UOMe-Ra
20
5
4
10
11
)
)
c(UAGCAUOMe
a Ribonucleosides were 2A-O-Fpmp protected. b Electrospray MS. c MALDI-TOF MS. d Estimated by PAGE.
for the cyclization reaction are: 0.15 M MSNT in pyridine, three treatments
(4 h + 4 h + overnight) with 20 equiv. MSNT each. Conditions for the
deprotection and cleavage reactions are: (i) Et3N–pyridine (1+1), 3 3 1 h;
(ii) 0.2 M tetramethylguanidinium syn-pyridine-2-aldoximate in dioxane–
water (1+1), 4 h + 4 h + overnight with 50 equiv. oximate; (iii) conc.
aqueous NH3, 55 °C, 12 h; (iv) 0.5 M AcONa, pH 4, 12 h, and then
neutralization with 3 M Tris·HCl, pH 8.
The synthesis of some larger circles was undertaken to
further evaluate the possibilities of the method. Several cyclic
oligoribonucleotides were obtained at the 1–2 mmol scale from
resins 1a and 1b. Results are shown in Table 1 (entries 6 to 11).
The cyclic products were submitted to Sephadex G-10 gel
filtration and HPLC or PAGE purification, and were charac-
terized as above.
Yields of crude products are generally lower than those
typically obtained in the synthesis of cyclic DNA. The low yield
obtained for c(U5T) (entry 8) and the difference in yield
between the two cyclic tetramers (entries 6 and 7) reflect the
difficulty in getting high and reproducible yields in the
cyclization reaction with MSNT. A 2A-O-methylribonucleotide
at the 3A end of the linear precursor seems to have a negative
effect on the cyclization yield of the hexamers (entries 10, 11),
which was not observed for a dinucleotide (entry 2). The
homogeneity of the crude products detached from the resin is
also slightly lower than in cyclic DNA synthesis. However, a
major HPLC peak or PAGE band is always obtained, thus
allowing easy purification of the circle and showing that the key
advantage of the method is preserved.
In conclusion, cyclic RNA can be obtained provided that the
linear precursor attached to the support has a 2A-deoxy-
ribonucleoside or a 2A-O-methylribonucleoside at the 3A end.
Such single modification in the sequence of the cyclic RNAs
should have little relevance for many purposes. For instance,
enzymatically circularized hammerhead ribozymes containing
non-nucleoside linkers have been shown to display increased
biological activity and reduced divalent metal ion require-
ment.18
1 P. Ross, H. Weinhouse, Y. Aloni, D. Michaeli, P. Weinberger-Ohana, R.
Mayer, S. Braun, E. de Vroom, G. A. van der Marel, J. H. van Boom and
M. Benziman, Nature, 1987, 325, 279.
2 C.-Y. L. Hsu and D. Dennis, Nucleic Acids Res., 1982, 10, 5637.
3 A. J. Zaug, P. J. Grabowski and T. R. Cech, Nature, 1983, 301, 578;
T. R. Cech, Annu. Rev. Biochem., 1990, 59, 543.
4 M. Egli, R. V. Gessner, L. D. Williams, G. J. Quigley, G. A. van der
Marel, J. H. van Boom, A. Rich and C. A. Frederick, Proc. Natl. Acad.
Sci. U.S.A., 1990, 87, 3235.
5 M. M. W. Mooren, S. S. Wijmenga, G. A. van der Marel, J. H. van Boom
and C. W. Hilbers, Nucleic Acids Res., 1994, 22, 2658.
6 G. L. Conn and D. E. Draper, Curr. Opin. Struct. Biol., 1998, 8, 278.
7 C.-Y. L. Hsu, D. Dennis and R. A. Jones, Nucleosides Nucleotides,
1985, 4, 377.
8 E. de Vroom, H. J. G. Broxterman, L. A. J. M. Sliedregt, G. A. van der
Marel and J. H. van Boom, Nucleic Acids Res., 1988, 16, 4607; C. Sund,
P. Agback and J. Chattopadhyaya, Tetrahedron, 1991, 47, 9659.
9 C. B. Reese and Q. Song, Nucleic Acids Res.,1999, 27, 963.
10 L. De Napoli, A. Galeone, L. Mayol, A. Messere, G. Piccialli and C.
Santacroce, J. Chem. Soc., Perkin Trans. 1, 1993, 747; L. De Napoli, A.
Galeone, L. Mayol, A. Messere, D. Montesarchio and G. Piccialli,
Bioorg. Med. Chem., 1995, 3, 1325.
11 S. Wang and E. T. Kool, Nucleic Acids Res., 1994, 22, 2326.
12 T. Pan, R. R. Gutell and O. C. Uhlenbeck, Science, 1991, 254, 1361;
C. Y. Chen and P. Sarnow, Science, 1995, 268, 415.
13 A. M. Diegelman and E. T. Kool, Nucleic Acids Res., 1998, 26, 3235.
14 E. Alazzouzi, N. Escaja, A. Grandas and E. Pedroso, Angew. Chem., Int.
Ed. Engl., 1997, 36, 1506.
Work is in progress to prepare larger, ‘all-ribonucleoside’
cyclic RNAs by circumventing the problem of the steric
hindrance at the 3A end phosphate.
This work was supported by the Ministerio de Educacio´n
(DGES, grant PB97-941) and the Generalitat de Catalunya
(Centre de Refere`ncia de Biotecnologia and SGR98-1).
15 M. A. Morgan, S. A. Kazakov and S. M. Hecht, Nucleic Acids Res.,
1995, 23, 3949.
16 K. K. Ogilvie, N. Y. Theriault, J.-M. Seifert, R. T. Pon and M. J. Nemer,
Can. J. Chem., 1980, 58, 2686.
17 M. V. Rao, C. B. Reese, V. Schehlmann and P. S. Yu, J. Chem. Soc.,
Perkin Trans. 1, 1993, 43; D. C. Capaldi and C. B. Reese, Nucleic Acids
Res., 1994, 22, 2209.
18 L. Wang and D. E. Ruffner, Nucleic Acids Res., 1998, 26, 2502; J. Am.
Chem. Soc., 1998, 120, 7684.
Notes and references
† Selected 31P NMR data (121.4 MHz, CDCl3) for 1a: dP 25.12. For 1b: dP
26.99. For 1c: dP 26.90.
‡ Oligonucleotide chains were assembled using 5A-O-DMT-nucleoside 3A-
cyanoethylphosphoramidites (2A-O-Fpmp-protected, when required) and
tetrazole for the coupling step, and ButOOH for the oxidation. Conditions
Communication 9/04851K
1594
Chem. Commun., 1999, 1593–1594